FDA Inspection 1253807 — Milbar Laboratories, Inc.

Milbar Laboratories, Inc. — FEI 2435254

The FDA completed an inspection of Milbar Laboratories, Inc. on November 7, 2024 in East Haven, CT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 7, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
East Haven, CT (United States)

Citations

IDCFRDescription
109821 CFR 211.22(c)Approve or reject procedures or specs
116921 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
117721 CFR 211.63Equipment Design, Size and Location
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
191221 CFR 211.166(a)Written program not followed
431421 CFR 211.84(d)(2)Reports of Analysis (Components)
435721 CFR 211.166(a)Results not used for expiration dates, storage cond.